Assessment of the Neuroprotective Effect of Green Synthesized Iron Oxide Nanoparticles Capped with Curcumin Against a Rat Model of Parkinson's Disease

Overview

Journal Iran J Basic Med Sci

Publisher Mashhad University of Medical Sciences

Specialty General Medicine

Date 2024 Jan 2

PMID 38164480

Authors

Yasser Ashry Khadrawy

Eman Nasr Hosny

Haitham Sharf Eldein Mohamed

Affiliations

Soon will be listed here.

Abstract

Objectives: The current study aims to investigate the protective effect of iron oxide nanoparticles capped with curcumin (FeONPs-Cur) against motor impairment and neurochemical changes in a rat model of Parkinson's disease (PD) induced by reserpine.

Materials And Methods: Rats were grouped into control, PD model induced by reserpine, and PD model treated with FeONPs-Cur (8 rats/group). The open field test was used to assess motor activity. The concentration of dopamine (DA), norepinephrine (NE), serotonin (5-HT), lipid peroxidation (MDA), reduced glutathione (GSH), and nitric oxide (NO), and the activities of Na,K,ATPase, acetylcholinesterase (AchE), and monoamine oxidase (MAO) were determined in the midbrain and striatum. Data were analyzed by ANOVA at -value<0.05.

Results: The PD model exhibited a decrease in motor activity. In the midbrain and striatum of the PD model, DA, NE, and 5-HT levels decreased significantly (-value<0.05). However, an increase in MAO, NO, and MDA was observed. GSH, AchE and Na,K,ATPase decreased significantly in the two brain areas. FeONPs-Cur prevented the decline of dopamine and norepinephrine and reduced oxidative stress in both areas. It also prevented the increased MAO activity in the two areas and the inhibited activity of AchE and Na,K,ATPase in the midbrain. These changes were associated with improvements in motor activity.

Conclusion: The present data indicate that FeONPs-Cur could prevent the motor deficits induced in the PD rat model by restoring dopamine and norepinephrine in the midbrain and striatum. The antioxidant activity of FeONPs-Cur contributed to its protective effect. These effects nominate FeONPs-Cur as an antiparkinsonian candidate.

Citing Articles

Emerging Promise of Green Synthesized Metallic Nanoparticles for the Management of Neurological Disorders.

Moghaddam Z, Esmaili Moghadam Z, Hamidi S, Azarfarin M, Salatin S Curr Pharm Des. 2024; 31(5):344-359.

PMID: 39400023 DOI: 10.2174/0113816128337464240930042205.

Curcumin: A Golden Approach to Healthy Aging: A Systematic Review of the Evidence.

Nunes Y, Mendes N, de Lima E, Chehadi A, Lamas C, Haber J Nutrients. 2024; 16(16).

PMID: 39203857 PMC: 11357524. DOI: 10.3390/nu16162721.

The Effects of Fisetin and Curcumin on Oxidative Damage Caused by Transition Metals in Neurodegenerative Diseases.

Bjorklund G, Oliinyk P, Khavrona O, Lozynska I, Lysiuk R, Darmohray R Mol Neurobiol. 2024; 62(1):1225-1246.

PMID: 38970766 DOI: 10.1007/s12035-024-04321-2.

References

Kondabolu K, Roberts E, Bucklin M, McCarthy M, Kopell N, Han X . Striatal cholinergic interneurons generate beta and gamma oscillations in the corticostriatal circuit and produce motor deficits. Proc Natl Acad Sci U S A. 2016; 113(22):E3159-68. PMC: 4896681. DOI: 10.1073/pnas.1605658113. View

Callio J, Oury T, Chu C . Manganese superoxide dismutase protects against 6-hydroxydopamine injury in mouse brains. J Biol Chem. 2005; 280(18):18536-42. PMC: 1885201. DOI: 10.1074/jbc.M413224200. View

Cavalcanti-Kwiatkoski R, Raisman-Vozari R, Ginestet L, Del Bel E . Altered expression of neuronal nitric oxide synthase in weaver mutant mice. Brain Res. 2010; 1326:40-50. DOI: 10.1016/j.brainres.2010.02.056. View

Chaudhuri K, Martinez-Martin P, Schapira A, Stocchi F, Sethi K, Odin P . International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson's disease: the NMSQuest study. Mov Disord. 2006; 21(7):916-23. DOI: 10.1002/mds.20844. View

Fernandes V, Santos J, Leao A, Medeiros A, Melo T, Izidio G . Repeated treatment with a low dose of reserpine as a progressive model of Parkinson's disease. Behav Brain Res. 2012; 231(1):154-63. DOI: 10.1016/j.bbr.2012.03.008. View

Antunes M, Ladd F, Ladd A, Moreira A, Boeira S, Souza L . Hesperidin protects against behavioral alterations and loss of dopaminergic neurons in 6-OHDA-lesioned mice: the role of mitochondrial dysfunction and apoptosis. Metab Brain Dis. 2020; 36(1):153-167. DOI: 10.1007/s11011-020-00618-y. View

Vergo S, Leander Johansen J, Leist M, Lotharius J . Vesicular monoamine transporter 2 regulates the sensitivity of rat dopaminergic neurons to disturbed cytosolic dopamine levels. Brain Res. 2007; 1185:18-32. DOI: 10.1016/j.brainres.2007.09.028. View

Tysnes O, Storstein A . Epidemiology of Parkinson's disease. J Neural Transm (Vienna). 2017; 124(8):901-905. DOI: 10.1007/s00702-017-1686-y. View

Naserzadeh P, Ashrafi Hafez A, Abdorahim M, Abdollahifar M, Shabani R, Peirovi H . Curcumin loading potentiates the neuroprotective efficacy of FeO magnetic nanoparticles in cerebellum cells of schizophrenic rats. Biomed Pharmacother. 2018; 108:1244-1252. DOI: 10.1016/j.biopha.2018.09.106. View

10.

Angelova P, Horrocks M, Klenerman D, Gandhi S, Abramov A, Shchepinov M . Lipid peroxidation is essential for α-synuclein-induced cell death. J Neurochem. 2015; 133(4):582-9. PMC: 4471127. DOI: 10.1111/jnc.13024. View

11.

GORUN V, Proinov I, Baltescu V, Balaban G, Barzu O . Modified Ellman procedure for assay of cholinesterases in crude enzymatic preparations. Anal Biochem. 1978; 86(1):324-6. DOI: 10.1016/0003-2697(78)90350-0. View

12.

Elbialy N, Aboushoushah S, Alshammari W . Long-term biodistribution and toxicity of curcumin capped iron oxide nanoparticles after single-dose administration in mice. Life Sci. 2019; 230:76-83. DOI: 10.1016/j.lfs.2019.05.048. View

13.

Kerenyi L, Ricaurte G, Schretlen D, McCann U, Varga J, Mathews W . Positron emission tomography of striatal serotonin transporters in Parkinson disease. Arch Neurol. 2003; 60(9):1223-9. DOI: 10.1001/archneur.60.9.1223. View

14.

Tsakiris S, Angelogianni P, Schulpis K, Stavridis J . Protective effect of L-phenylalanine on rat brain acetylcholinesterase inhibition induced by free radicals. Clin Biochem. 2001; 33(2):103-6. DOI: 10.1016/s0009-9120(99)00090-9. View

15.

Khadrawy Y, Hosny E, Magdy M, Mohammed H . Antidepressant effects of curcumin-coated iron oxide nanoparticles in a rat model of depression. Eur J Pharmacol. 2021; 908:174384. DOI: 10.1016/j.ejphar.2021.174384. View

16.

Mirza A, Kareem A, Nami S, Khan M, Rehman S, Bhat S . Biogenic synthesis of iron oxide nanoparticles using Agrewia optiva and Prunus persica phyto species: Characterization, antibacterial and antioxidant activity. J Photochem Photobiol B. 2018; 185:262-274. DOI: 10.1016/j.jphotobiol.2018.06.009. View

17.

Eve D, Nisbet A, Kingsbury A, Hewson E, Daniel S, Lees A . Basal ganglia neuronal nitric oxide synthase mRNA expression in Parkinson's disease. Brain Res Mol Brain Res. 1998; 63(1):62-71. DOI: 10.1016/s0169-328x(98)00259-9. View

18.

Zhang Y, Wang Z, Li X, Wang L, Yin M, Wang L . Dietary Iron Oxide Nanoparticles Delay Aging and Ameliorate Neurodegeneration in Drosophila. Adv Mater. 2015; 28(7):1387-93. DOI: 10.1002/adma.201503893. View

19.

Kim G, Kim J, Rhie S, Yoon S . The Role of Oxidative Stress in Neurodegenerative Diseases. Exp Neurobiol. 2015; 24(4):325-40. PMC: 4688332. DOI: 10.5607/en.2015.24.4.325. View

20.

Perry E, Curtis M, Dick D, Candy J, Atack J, Bloxham C . Cholinergic correlates of cognitive impairment in Parkinson's disease: comparisons with Alzheimer's disease. J Neurol Neurosurg Psychiatry. 1985; 48(5):413-21. PMC: 1028327. DOI: 10.1136/jnnp.48.5.413. View